Workflow
Company acquisition valuation
icon
Search documents
Clearwater Analytics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Clearwater Analytics Holdings, Inc. - CWAN
Prnewswire· 2026-01-24 00:32
Core Viewpoint - The proposed sale of Clearwater Analytics Holdings, Inc. to Permira and Warburg Pincus is under investigation to assess whether the offered price of $24.55 per share adequately reflects the company's value [1]. Group 1: Transaction Details - Clearwater Analytics shareholders will receive $24.55 in cash for each share they own as part of the proposed transaction [1]. - The law firm Kahn Swick & Foti, LLC is investigating the adequacy of this consideration and the process leading to the proposed sale [1]. Group 2: Legal Rights and Contact Information - Shareholders who believe the transaction undervalues Clearwater Analytics can contact Kahn Swick & Foti to discuss their legal rights without any obligation or cost [2]. - Kahn Swick & Foti provides contact information for inquiries, including a toll-free number and an email address for the Managing Partner [2].
Inspirato Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inspirato Incorporated - ISPO
Prnewswire· 2026-01-16 19:10
Core Viewpoint - The proposed sale of Inspirato Incorporated to Exclusive Investments LLC is under investigation to assess whether the offered price of $4.27 per share adequately reflects the company's value [1]. Group 1: Transaction Details - Shareholders of Inspirato will receive $4.27 in cash for each share they own as part of the proposed transaction [1]. - Kahn Swick & Foti, LLC is investigating the adequacy of this consideration and the process leading to the proposed sale [1]. Group 2: Legal Rights and Contact Information - Individuals who believe the transaction undervalues the company can discuss their legal rights with Kahn Swick & Foti, LLC without obligation or cost [2]. - Contact information for KSF Managing Partner Lewis S. Kahn is provided for inquiries regarding the proposed sale [2].
Y-MABS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Y-mAbs Therapeutics, Inc. - YMAB
GlobeNewswire News Room· 2025-08-20 01:05
Core Viewpoint - The proposed sale of Y-mAbs Therapeutics, Inc. to SERB Pharmaceuticals is under investigation to assess whether the offered price of $8.60 per share adequately reflects the company's value [1]. Group 1: Transaction Details - Shareholders of Y-mAbs will receive $8.60 in cash for each share they own as part of the proposed transaction [1]. - The transaction is structured as a tender offer, indicating that timing may be critical for shareholders [3]. Group 2: Legal Investigation - Kahn Swick & Foti, LLC is investigating the adequacy of the proposed sale price and the process leading to this valuation [1]. - The firm is open to discussions regarding legal rights related to the proposed sale, encouraging shareholders to reach out for more information [2].